14 February 2022 - Ensuring high quality, affordable generic drugs are available to the American public. ...
13 January 2022 - The FDA’s Center for Drug Evaluation and Research has issued its report, Advancing Health Through Innovation: New ...
17 December 2020 - Today, the U.S. FDA published an update to the “List of Off-Patent, Off-Exclusivity Drugs without an Approved ...
19 February 2020 - Safe, effective, high-quality generic drugs play a vital role in the U.S. health care system. ...
17 January 2020 - Failure to report the results of a clinical trial can distort the evidence base for clinical practice, ...
29 August 2019 - A Food and Drug Administration proposal to substitute detailed reviews of new drugs written by specific ...
16 January 2019 - One year after the FDA launched a voluntary pilot program to release clinical study reports, which ...
2 October 2017 - The FDA’s adverse event reporting system is a database that contains adverse event reports, medication error reports ...
20 February 2017 - The US FDA has been the standard of drug regulation worldwide for decades. ...
5 January 2017 - This letter is the Director's first annual report to various stakeholders. It summarises what Center have ...
12 October 2016 - The US FDA published final Fiscal Year 2016 abbreviated new drug application (ANDA) approvals earlier this ...
7 October 2016 - PD-1 value-based price benchmarks are updated while the main conclusions of the analysis remain unchanged. ...